København S, Denmark

Klaus Koefoed

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 8.3

ph-index = 5

Forward Citations = 79(Granted Patents)


Location History:

  • Lyngby, DK (2017 - 2020)
  • København S, DK (2015 - 2022)
  • Copenhagen, DK (2011 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Klaus Koefoed: A Pioneer in Antibody Innovation

Introduction

Klaus Koefoed is a notable inventor based in København S, Denmark, recognized for his significant contributions to the field of biotechnology. With a remarkable portfolio of 13 patents, he has paved the way for advancements in cancer treatment through innovative antibody therapies.

Latest Patents

Koefoed's latest inventions include two groundbreaking patents:

1. **Anti-TIM-3 antibodies and compositions**: This invention pertains to anti-TIM-3 antibodies and their compositions, designed to enhance immunity in patients, particularly for cancer treatment.

2. **Anti-PD-1 antibodies and compositions**: This patent focuses on anti-PD-1 antibodies and the methods involved in utilizing these antibodies for treating diseases related to PD-1 activity, also with an emphasis on cancer.

Career Highlights

Throughout his career, Klaus Koefoed has worked with prominent companies in the biotechnology sector, including Symphogen A/S and Genentech, Inc. His role in these organizations has been crucial in advancing research and development in monoclonal antibody therapies.

Collaborations

In his journey, Koefoed has collaborated with esteemed colleagues such as Mikkel Wandahl Pedersen and Peter Sejer Andersen. Together, they have fostered innovation and contributed to the comprehension of antibody-mediated therapies.

Conclusion

Klaus Koefoed stands out as an influential figure in the world of biopharmaceuticals, thanks to his innovative patent portfolio and collaborative spirit. His work continues to inspire advances in cancer treatment, highlighting the importance of antibody-based therapies in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…